<DOC>
	<DOCNO>NCT01341431</DOCNO>
	<brief_summary>The purpose study evaluate efficacy repeat ( monthly ) injection bee venom motor symptom Parkinson 's disease period one year , also potential effect treatment disease progression compare placebo ( saline injection ) .</brief_summary>
	<brief_title>Bee Venom Treatment Parkinson Disease</brief_title>
	<detailed_description>The investigator plan assess potential efficacy repeat ( monthly ) injection bee venom motor symptom Parkinson disease period one year . The investigator also assess potential effect treatment disease progression . All assessment conduct comparison placebo ( saline injection ) .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients suffer Parkinson disease accord Parkinson 's Disease Society Brain Bank criterion ( Hughes et al. , 1992 ) Age &gt; 40 an ( exclusion juvenile form ) Hoehn Yahr stage 1,53 Pathological DaTSCAN MRI exclude atypical secondary form parkinsonism Negative test bee venom ( intradermoreaction ) Affiliated French Social Security System Parkinson disease Hoehn &amp; Yahr stage &lt; 1,5 &gt; 3 Positive intradermoreaction bee venom IgE positive bee venom Known allergy bee venom Contraindications treatment bee venom ( AlyostalÂ® ) Atypical secondary parkinsonian syndrome ( verified MRI ) Treatment antipsychotic past 6 month Cardiac , hepatic renal failure Normal DaTSCAN Contraindications MRI scan Pregnancy Major depression severe acute/ongoing psychiatric disorder Cognitive impairment ( MMS &gt; 24 ) Patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Parkinson disease</keyword>
	<keyword>Bee venom</keyword>
	<keyword>Motor fluctuation</keyword>
	<keyword>Disease progression</keyword>
</DOC>